Terms: = Pancreatic cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Diagnosis
4 results:
1. Evaluation of miR-429 as a novel serum biomarker for pancreatic ductal adenocarcinoma and analysis its tumor suppressor function and target genes.
Huang WT; Lin TS; Wu JY; Hong JM; Chen YL; Qiu FN
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4638-4653. PubMed ID: 35856354
[TBL] [Abstract] [Full Text] [Related]
2. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.
Lu Y; Li C; Chen H; Zhong W
Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393
[TBL] [Abstract] [Full Text] [Related]
3. Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984-2005: a population study.
Reid-Lombardo KM; St Sauver J; Li Z; Ahrens WA; Unni KK; Que FG
Pancreas; 2008 Aug; 37(2):139-44. PubMed ID: 18665073
[TBL] [Abstract] [Full Text] [Related]
4. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.
Gibril F; Schumann M; Pace A; Jensen RT
Medicine (Baltimore); 2004 Jan; 83(1):43-83. PubMed ID: 14747767
[TBL] [Abstract] [Full Text] [Related]
